Alcoholic hepatology: Advances in understanding the cellular response to stress and hepatic lysis

Authors

Keywords:

LIVER CIRRHOSIS, ALCOHOLIC, LIVER DISEASES, HEPATITIS, PATIENT.

Abstract

Introduction: alcoholic hepatology is a field of medicine that focuses on the study, diagnosis and treatment of liver diseases caused by excessive and prolonged alcohol consumption.

Objective: epidemiologists should see what is the main problem that affects the population where it is also responsible for disseminating the means and preventive measures to prevent alcohol consumption harm in people's lives.

Methods: the present research is qualitative because qualitative methods are applied for the collection of information. It is descriptive in scope because it will characterize the importance of early detection of alcoholic liver disease. It is applied because it will provide the doctor Hepatologist Juan José Suárez Martínez of the Hospital Metropolitano de Quito.

Results: in recent years, significant advances have been made in the understanding of the cellular response to stress in alcoholic hepatology. Alcohol-related liver disease is the most common cause of advanced liver disease and cirrhosis. According to the World Health Organization, the proportion of alcohol-related liver cirrhosis is 73,8 % in men and 56,3 % in women, which include steatohepatitis, cirrhosis, and hepatocellular carcinoma.

Conclusions: hepatic pathology can manifest in different forms, such as hepatitis, cirrhosis, hepatic steatosis, nonalcoholic fatty liver disease, autoimmune hepatitis, primary sclerosing cholangitis, among others.

 

Downloads

References

1. Galicia-Moreno M, Gutiérrez-Reyes G. Papel del estrés oxidativo en el desarrollo de la enfermedad hepática alcohólica. Rev Gastroenterol Mex [Internet]. 2014 [citado 29/12/2024]; 79(2): 135–44. Available from: https://www.sciencedirect.com/science/article/pii/S0375090614000329

2. Gregorio Robles E. Participación de las catepsinas b y s en la respuesta inflamatoria hepática [Internet]. Universidad de Barcelona; 2019 [citado 29/12/2024]. Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=299336

3. Augustín Bandera V, Villena-Ruiz M Ángeles, Granados Pacheco F, Robles Cabeza L, Aguilar García JA. Síndrome de lisis tumoral espontáneo. Rev Esp Casos Clin Med Intern [Internet]. 31 de agosto de 2020 [citado 29/12/2024]; 5(2): 65-7. Disponible en: https://www.reccmi.com/RECCMI/article/view/494

4. Tubío, A. Figueroa, et al. "Protocolo diagnóstico y tratamiento de la hepatitis alcohólica." Medicine-Programa de Formación Médica Continuada Acreditado[Internet]. 2020 [citado 29/12/2024]; 13(4): 220-224. Disponible en: https://doi.org/10.1016/j.med.2020.02.006

5. Martínez Vargas E, Cuervo Moreno A. Distribución de las principales enfermedades hepáticas crónicas en Colombia desde 2015 hasta 2015 2019 para determinar si se requiere una estrategia de salud pública [Internet]. Bogotá D.C.: Fundación Universitaria Juan N. Corpas; 2021 [citado 12/03/2025]. Disponible en: https://repositorio.juanncorpas.edu.co/handle/001/121

6. Aristizábal-García C, Urrea-Pineda LY, Donado-Gómez JH. Caracterización clínico-epidemiológica de los pacientes sometidos a trasplante hepático por cirrosis alcohólica en el Hospital Pablo Tobón Uribe de Medellín entre 2004 y 2015. Hepatología [Internet]. 2023 [citado 29/12/2024]; 4(1): 13-24. Disponible en: https://revistahepatologia.org/index.php/hepa/article/view/66

7. Patel R, Mueller M. Alcoholic Liver Disease. 2023 Jul 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [citado 29/12/2024]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31536239/

8. Aller R, Calleja JL, Crespo J, Romero-Gómez M, Turnes J, Benmarzouk-Hidalgo O J, et al (2023). Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi. Gastroenterología y Hepatología [Internet]. 2023 [citado 29/12/2024]; 47(4): 337-346. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210570523003631

9. LLOSA TEJADA R. Hepatitis alcohólica. Rev Méd Hered [Internet]. 2 de octubre de 2013 [citado 12/03/2025]; 2(1). Disponible en: https://revistas.upch.edu.pe/index.php/RMH/article/view/300

10. Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, et al. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol [Internet]. 2019 Dec [citado 12/03/2025]; 42(10): 657-676. Disponible: https://pubmed.ncbi.nlm.nih.gov/31771785/

11. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology [Internet]. 2011 Nov [citado 12/03/2025]; 141(5): 1572-85. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21920463/
13. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet [Internet]. 1995 [citado 12/03/2025]; 346(8981): 987-990. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7475591/

14. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol [Internet]. 2018 [citado 12/03/2025]; 113(2): 175-194. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29336434/

15. Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnóstico y tratamiento de enfermedades hepáticas asociadas al alcohol: Guía práctica de 2019 de la Asociación Estadounidense para el Estudio de Enfermedades Hepáticas. Hepatología [Internet]. 2020 [citado 12/03/2025]; 71(1): 306-333. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31314133/

16. Rehm J, et al. Carga mundial de enfermedades y lesiones y costo económico atribuible al consumo de alcohol y los trastornos por consumo de alcohol. Lanceta [Internet]. 2009 [citado 12/03/2025]; 373(9682): 2223-2233. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19560604/

17. Lucey MR, Mathurin P, Morgan TR. Hepatitis alcohólica. N Engl J Med [Internet]. 2009 [citado 12/03/2025]; 360(26): 2758-2769. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19553649/

18. Singal AK, et al. Hepatitis alcohólica: desafíos actuales y direcciones futuras. Clin Gastroenterol Hepatol [Internet]. 2014 [citado 12/03/2025]; 12(4): 555-564. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23811249/

19. López-Larramona G, Lucendo Alfredo J, González-Delgado L. Enfermedad hepática alcohólica y alteraciones de la densidad mineral ósea. Rev. esp. enferm. dig. [Internet]. 2013 Dic [citado 12/03/2025]; 105(10): 609-621. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013001000006&lng=es.

20. Neira-Moreno JP. Trasplante en la enfermedad hepática por alcohol. Hepatol. [Internet]. 23 de enero de 2021 [citado 12/03/2025]; 2(1): 199-210. Disponible en: https://revistahepatologia.org/index.php/hepa/article/view/22

21. Morgan TR, Chao D, Botwin G. Tratamiento de la hepatitis alcohólica. Clin Liver Dis (Hoboken) [Internet]. 2013 Oct 16 [citado 12/03/2025]; 2(Suppl 4): S56Š–S60Š. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6519333/

22. Asociación Europea para el Estudio del Hígado (EASL). Guías clínicas prácticas de la EASL: tratamiento de la enfermedad hepática alcohólica. J Hepatol [Internet]. 2012 [citado 12/03/2025]; 57(2): 399-420. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22633836/

23. Louvet A, et al. El modelo de Lille: una nueva herramienta para la estrategia terapéutica en pacientes con hepatitis alcohólica grave tratados con esteroides. Hepatología [Internet]. 2007 [citado 12/03/2025]; 45(6): 1348-1354. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17518367/

24. Altamirano J, et al. Un sistema de puntuación histológica para el pronóstico de pacientes con hepatitis alcohólica. Gastroenterología [Internet]. 2014 [citado 12/03/2025]; 146(5): 1231-1239.e1-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24440674/

Downloads

Published

2025-03-13

How to Cite

1.
Moina-Veloz Álvaro P, Guilcaso-Nieto KP, Freire-Tenecota AB, Gutiérrez-Navas T de J. Alcoholic hepatology: Advances in understanding the cellular response to stress and hepatic lysis. Univ. Méd. Pinareña [Internet]. 2025 Mar. 13 [cited 2025 Apr. 27];21(1):e1418. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/1418

Issue

Vol. 21 No. 1 (2025): Publicación Continua

Section

Review article

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).